Home
LiteratureArticle Details
PMID: 7563210
Published · ppublish
English
Letter
Comment
Paclitaxel in doxorubicin-resistant metastatic breast cancer patients.
Abstract
暂无摘要
MeSH Terms
Antibiotics, Antineoplastic/therapeutic use
Antineoplastic Agents, Phytogenic/therapeutic use
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Breast Neoplasms/drug therapy,pathology
Docetaxel
Doxorubicin/therapeutic use
Drug Resistance
Female
Humans
Neoplasm Metastasis
Paclitaxel/analogs & derivatives,therapeutic use
Taxoids
Chemicals
Antibiotics, Antineoplastic
Antineoplastic Agents, Phytogenic
Taxoids
Docetaxel
Doxorubicin
Paclitaxel
Article Info
Journal
Journal of the National Cancer Institute
Abbr.
J Natl Cancer Inst
ISSN
0027-8874
Published
1995-11-01
Pages
1642
Language
English
Region
United States
NLM ID
7503089
Subset
IM
Corrections
CommentOn
Analysis Services
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
